Tag: ICI and TKI

Stereotactic radiosurgery promising for patients with multiple brain metastases

Atezolizumab, Vemurafenib, and Cobimetinib in Melanoma With CNS Metastases

byDaniel Goldshteinand1 others

October 9, 2023

1. Intracranial objective response rate was 42% in the BRAF V600 mutation-positive cohort and 27% in the BRAFV600 wild-type cohort. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

No Result

View All Result

Tag: ICI and TKI

Atezolizumab, Vemurafenib, and Cobimetinib in Melanoma With CNS Metastases

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits